| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 7.829 | 12.568 | 14.586 | 18.757 | 18.754 | 20.939 | 34.082 | 28.316 | 26.339 | 24.274 |
| Total Income - EUR | 7.652 | 12.618 | 14.603 | 18.777 | 20.272 | 20.988 | 35.149 | 28.375 | 26.347 | 24.288 |
| Total Expenses - EUR | 6.527 | 11.809 | 9.560 | 9.317 | 9.535 | 9.792 | 15.401 | 11.815 | 13.276 | 15.200 |
| Gross Profit/Loss - EUR | 1.124 | 809 | 5.043 | 9.460 | 10.737 | 11.196 | 19.748 | 16.559 | 13.071 | 9.089 |
| Net Profit/Loss - EUR | 895 | 611 | 4.897 | 9.273 | 10.534 | 10.993 | 19.396 | 16.290 | 12.807 | 8.420 |
| Employees | 1 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Prikimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 759 | 627 | 495 |
| Current Assets | 16.714 | 17.603 | 19.491 | 29.957 | 33.279 | 37.186 | 52.702 | 48.488 | 46.488 | 41.882 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 212 | 1.036 | 554 | 947 | 1.231 | 206 | 2.699 | 0 | 3.501 | 0 |
| Cash | 16.503 | 16.567 | 18.938 | 29.010 | 32.048 | 36.979 | 50.003 | 48.488 | 42.987 | 41.882 |
| Shareholders Funds | 12.397 | 12.881 | 17.560 | 26.511 | 31.474 | 36.909 | 50.635 | 47.625 | 46.137 | 40.226 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.317 | 4.722 | 1.931 | 3.446 | 1.805 | 277 | 2.067 | 1.622 | 978 | 2.151 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Prikimed S.r.l.